Know Cancer

or
forgot password

DNA Microarray Analysis of Endoscopic Ultrasound-Guided Fine Needle Aspiration Biopsies to Discriminate Benign From Malignant Pancreatic Lesions


N/A
18 Years
N/A
Not Enrolling
Both
Pancreas Cancer

Thank you

Trial Information

DNA Microarray Analysis of Endoscopic Ultrasound-Guided Fine Needle Aspiration Biopsies to Discriminate Benign From Malignant Pancreatic Lesions


Inclusion Criteria:



- Adults aged 18 or older who are able to give informed consent who present for an
endoscopic ultrasound to evaluate a pancreas mass or cyst or for suspicion of cancer.

Exclusion Criteria:

- Unable to give informed consent, pregnant or nursing, contraindication to endoscopic
ultrasound, no mass or cyst found on ultrasound

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Gene expression profile is 95% accurate in diagnosis of malignancy

Outcome Time Frame:

after enrollment of 50 patients

Safety Issue:

No

Principal Investigator

Sarah Rodriguez, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Oregon Health and Science University

Authority:

United States: Institutional Review Board

Study ID:

IRB4191

NCT ID:

NCT00680420

Start Date:

June 2008

Completion Date:

June 2011

Related Keywords:

  • Pancreas Cancer
  • pancreas cancer
  • pancreas cyst
  • DNA microarray
  • Pancreatic Neoplasms

Name

Location

Oregon Health and Science UniversityPortland, Oregon  97201